SARS-CoV-2 Envelope Protein (SARS-CoV-2 E)
-
- Target Alle SARS-CoV-2 Envelope (SARS-CoV-2 E) Produkte
- SARS-CoV-2 Envelope (SARS-CoV-2 E)
- Protein-Typ
- Recombinant
-
Spezies
- SARS Coronavirus (SARS-CoV)
-
Quelle
- Escherichia coli (E. coli)
- Applikation
- ELISA, Western Blotting (WB)
- Verwendungszweck
- E (SARS-CoV) Recombinant Protein
- Produktmerkmale
- SARS-CoV E (1 a.a. - 76 a.a.) recombinant protein expressed in Escherichia coli.
- Aufreinigung
- Escherichia coli expression system
-
SARS-CoV-2 Envelope (SARS-CoV-2 E) (AA 1-75) (Active) protein (His-Avi Tag)
SARS-CoV-2 E Spezies: SARS Coronavirus-2 (SARS-CoV-2) Wirt: Escherichia coli (E. coli) Recombinant > 95 % by SDS-PAGE. SDS Active
SARS-CoV-2 Envelope (SARS-CoV-2 E) protein (His tag,GST tag)SARS-CoV-2 E Spezies: SARS Coronavirus-2 (SARS-CoV-2) Wirt: Escherichia coli (E. coli) Recombinant >90 % as determined by SDS-PAGE. SDS
-
- Applikationshinweise
-
ELISA
IgG/IgM detection
Western Blot
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In 50 mM Tris-HCl, 60 mM NaCl (50 % glycerol).
- Lagerung
- 4 °C,-20 °C
-
- Target
- SARS-CoV-2 Envelope (SARS-CoV-2 E)
- Andere Bezeichnung
- E SARS-CoV-2 (SARS-CoV-2 E Produkte)
- Synonyme
- envelope protein Protein, E Protein
-
